- Home
- MBC vs AMPH Comparison
MBC vs AMPH Comparison
Compare MBC & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBC
- AMPH
- Stock Information
- Founded
- MBC 1954
- AMPH 1996
- Country
- MBC United States
- AMPH United States
- Employees
- MBC N/A
- AMPH N/A
- Industry
- MBC Agricultural Chemicals
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- MBC Industrials
- AMPH Health Care
- Exchange
- MBC Nasdaq
- AMPH Nasdaq
- Market Cap
- MBC 1.4B
- AMPH 1.1B
- IPO Year
- MBC N/A
- AMPH 2014
- Fundamental
- Price
- MBC $10.20
- AMPH $24.56
- Analyst Decision
- MBC Strong Buy
- AMPH Hold
- Analyst Count
- MBC 1
- AMPH 5
- Target Price
- MBC $15.00
- AMPH $38.00
- AVG Volume (30 Days)
- MBC 779.8K
- AMPH 468.8K
- Earning Date
- MBC 08-05-2025
- AMPH 08-06-2025
- Dividend Yield
- MBC N/A
- AMPH N/A
- EPS Growth
- MBC N/A
- AMPH N/A
- EPS
- MBC 0.77
- AMPH 2.77
- Revenue
- MBC $2,722,600,000.00
- AMPH $730,659,000.00
- Revenue This Year
- MBC N/A
- AMPH $0.67
- Revenue Next Year
- MBC $4.37
- AMPH $5.18
- P/E Ratio
- MBC $13.23
- AMPH $8.83
- Revenue Growth
- MBC 1.30
- AMPH 8.05
- 52 Week Low
- MBC $9.63
- AMPH $22.64
- 52 Week High
- MBC $20.67
- AMPH $53.96
- Technical
- Relative Strength Index (RSI)
- MBC 45.26
- AMPH 42.37
- Support Level
- MBC $9.86
- AMPH $25.19
- Resistance Level
- MBC $10.35
- AMPH $26.06
- Average True Range (ATR)
- MBC 0.39
- AMPH 0.76
- MACD
- MBC 0.03
- AMPH -0.14
- Stochastic Oscillator
- MBC 37.50
- AMPH 6.89
About MBC MasterBrand Inc.
MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers and builders.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.